The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2017
Filed:
Nov. 07, 2012
Applicant:
The University of Queensland, Queensland, AU;
Inventors:
David Fairlie, Mt Ommaney, AU;
Robert C. Reid, Chelmer, AU;
Assignee:
THE UNIVERSITY OF QUEENSLAND, St. Lucia, Queensland, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 263/34 (2006.01); C07D 271/06 (2006.01); C07D 401/12 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 333/38 (2006.01); C07D 271/10 (2006.01); C07D 277/56 (2006.01); C07D 307/68 (2006.01); C07D 403/12 (2006.01); C07D 233/90 (2006.01); A61K 39/39 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07D 263/34 (2013.01); A61K 39/39 (2013.01); C07D 233/90 (2013.01); C07D 271/06 (2013.01); C07D 271/10 (2013.01); C07D 277/56 (2013.01); C07D 307/68 (2013.01); C07D 333/38 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); A61K 2039/55511 (2013.01);
Abstract
Heterocyclic compounds that modulate C3a receptors and their use in the treatment or prevention of inflammatory diseases, infectious diseases, cancers, metabolic disorders, obesity, type 2 diabetes, metabolic syndrome and associated cardiovascular diseases are described. The use of the compounds in stimulating or suppressing an immune response is also described together with pharmaceutical compositions comprising the compounds or their pharmaceutically acceptable salts.